The FDA says it will use artificial intelligence to expedite the approval of new drugs and devices. Investigators with the ...

Creating clear regulatory frameworks and reimbursement standards can help ensure the responsible and effective integration of ...

The ArteraAI prostate test uses artificial intelligence and biomarkers to predict if standard hormone therapy will be ...

There is an immediate need for a new, agile process that helps everyday people find safe and trustworthy mental health AI ...

Digital transformation in healthcare accelerates adoption of AI-enabled monitoring solutions across global marketsDelray ...

Walmart recalls shrimp in 13 states after FDA finds radioactive contamination. OpenAI challenger Manus hits $90M revenue run ...

The approval of ArteraAI Prostate by the FDA as a software as a medical device (SaMD) means it can now be used at the point ...

ORLANDO, FLORIDA / ACCESS Newswire / August 19, 2025 / RedChip Companies, an international investor relations, media, and ...

Signos announced today that it launched its FDA-cleared over-the-counter glucose monitoring system for weight management.

The rally in the market came as the approval made PAPZIMEOS the first and only FDA-approved therapy for adult RRP patients.

Nerveblox, the ultrasound AI for regional anaesthesia receives US FDA 510(k) clearance: Ankara Wednesday, August 20, 2025, 15:00 Hrs [IST] Nerveblox, an AI software solution by Sm ...

The FDA’s De Novo authorization for the tool establishes a new product code category for future AI-powered digital pathology risk-stratification tools.